THE Scottish Medicines 足Consortium will announce its decision on the first ever 足targeted chemotherapy treatment for breast cancer on Monday. Decision to be made on breast cancer drug THE Scottish Medicines 足Consortium will announce its decision on the first ever 足targeted chemotherapy treatment for breast cancer on Monday.Kadcyla is designed specifically for secondary breast cancer and has been shown to provide women with six months, or more, extra time.If approved, women living in Scotland will have routine access to this drug on the NHS.NICE was forced to reject Kadcyla in August for routine use on the NHS in England and Wales on the basis that it was just too expensive to be deemed cost-effective. 